by now you have figured out I am obsessive compulsive
a few more questions
1. why did they do the November 15 financing if they already did 2 financings in 2010 ? if mtx 180 would bring in money ? what is the need ?
2.. why did Paul Turner step down as director
3... why did Paul Turner sell shares
AT THE MOMENT OF GLORY YEARS IN THE TESTING AND APPROVAL HAVING GOTTEN OVER THE 2008 MTX 100 FIASCO
if the mtx 180 is GREAT !!! why does Paul Turner step down now in his moment of Glory ?????
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 20, 2010, BSD Medical Corporation,
(the "Company") received notification from Paul F. Turner requesting that he not be nominated for reelection as a Director of the Company at the Company's next annual meeting of shareholders,
which will be held on February 2, 2011. Mr. Turner has served as a Director of the Company since 1994 and in various capacities with the Company as an employee and executive officer since 1978. The Company recognizes and appreciates Mr. Turner's significant leadership and contributions to the development of the Company's technology.
In addition, effective as of December 22, 2010, Mr. Turner will relinquish his title and duties as Senior Vice President, but will continue to serve as Chief Technology Officer for the Company. In such role, Mr. Turner will not provide any significant policy making functions, but will lead the Company's research activities for its hyperthermia and ablation products. The Corporate Governance and Nominating Committee of the Company's Board of Directors has determined that, in light of Mr. Turner's revised duties, he will no longer be designated as an executive officer pursuant to Item 401(b) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended. The Company looks forward to its continued association with Mr. Turner and to his contributions to the Company's progress.